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Amelogenesis imperfecta (AI) is a genetically and clinically heterogeneous group of inherited dental enamel
defects. Commonly described as an isolated trait, it may be observed concomitantly with other orodental and/or
systemic features such as nephrocalcinosis in Enamel Renal Syndrome (ERS, MIM#204690), or gingival hyperplasia in
Amelogenesis Imperfecta and Gingival Fibromatosis Syndrome (AIGFS, MIM#614253). Patients affected by ERS/AIGFS
present a distinctive orodental phenotype consisting of generalized hypoplastic AI affecting both the primary and
permanent dentition, delayed tooth eruption, pulp stones, hyperplastic dental follicles, and gingival hyperplasia
with variable severity and calcified nodules. Renal exam reveals a nephrocalcinosis which is asymptomatic in
children affected by ERS. FAM20A recessive mutations are responsible for both syndromes. We suggest that AIGFS
and ERS are in fact descriptions of the same syndrome, but that the kidney phenotype has not always been
investigated fully in AIGFS. The aim of this review is to highlight the distinctive and specific orodental features of
patients with recessive mutations in FAM20A. We propose ERS to be the preferred term for all the phenotypes arising
from recessive FAM20A mutations. A differential diagnosis has to be made with other forms of AI, isolated or syndromic,
where only a subset of the clinical signs may be shared. When ERS is suspected, the patient should be assessed by a
dentist, nephrologist and clinical geneticist. Confirmed cases require long-term follow-up. Management of the
orodental aspects can be extremely challenging and requires the input of multi-disciplinary specialized dental team,
especially when there are multiple unerupted teeth.
Keyword: Enamel Renal Syndrome (ERS), Amelogenesis Imperfecta and Gingival Fibromatosis syndrome (AIFGS),
Enamel Dysplasia with Hamartomatous atypical Follicular Hyperplasia Syndrome (EDHFH), Amelogenesis Imperfecta,
Enamel defect, Delayed tooth eruption, Intra-pulpal calcification, Gingival hyperplasia, FAM20AClassification
Amelogenesis imperfecta (AI) is a genetically and clinically
heterogeneous group of inherited dental enamel defects.
The enamel defects can be quantitative and/or qualitative.
Reduced enamel thickness, typically with normal hard-
ness is classified as hypoplastic AI, whereas reduced
hardness, discoloration with normal thickness is termed
hypomineralised AI, that incorporates hypocalcified and* Correspondence: murielmolla@gmail.com
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less otherwise stated.hypomaturation AI subtypes. Fourteen different AI sub-
types have been described, distinguished by clinical de-
scription and mode of inheritance, although increasingly
the emphasis is on genetic classification as insight into the
underlying molecular changes increases. All inheritance
patterns have been reported, including dominant, reces-
sive and X-linked inheritance with various degrees of
penetrance [1,2]. AI, commonly described as an isolated
trait, may be observed concomitantly with a number of
variable dental and/or systemic disorders [3,4]. Initially de-
scribed by MacGibbon in 1972 [5], many cases with en-
amel defects associated with nephrocalcinosis have since
been reported, either under the name “Amelogenesisd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribu-
ed the original work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article, un-
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“Enamel Renal Syndrome” (ERS, MIM#204690) [16].
Forty years after MacGibbon’s case report, next gener-
ation sequencing was used to identify recessive mutations
in the FAM20A (family with sequence similarities 20
member A) gene in 17 families with ERS [17,18]. FAM20A
mutations were also identified as the cause of “Amelogen-
esis Imperfecta and Gingival Fibromatosis Syndrome”
(AIGFS, MIM#614253) [19-23]. A detailed review of the
clinical aspects of patients affected by these two syn-
dromes reveals that the dental phenotype in both cases is
in fact the same and that the kidney phenotype has not
been investigated fully in AIGFS patients. Therefore reces-
sive FAM20A mutations lead to only one disease with dis-
tinctive oral phenotype frequently associated with renal
calcification.
Epidemiology
Collectively, the various forms of AI are common, with
prevalence rates varying from 1/700 to 1/14,000 in new-
borns, depending on the population studied [24,25]. A
review of the clinical cases in the literature indicates that
AI associated with the key features of ERS/AIGFS has been
reported but named differently: only AI [26,27], AI with
inter-radicular dentine dysplasia [28], AI with gingival fibro-
matosis [20,22,29,30], AI with odontogenic fibroma-like
hamartomas around non-erupted teeth [31-35], AI with
crown resorption [36] and AI with unerupted teeth [37].
To date, 34 articles have reported ERS-like cases (Table 1
and Additional file 1). Only 16 included a complete analysis
of both dental/oral and renal phenotypes. Since the renal
status was not systematically analyzed in these cases, ERS
has been underestimated. Nevertheless, all together less
than one hundred cases have been reported in the world.
The prevalence of ERS is still unknown. In Israel, where the
prevalence of AI is 1/8000, a study conducted on 70.359 af-
fected children reported only 1 autosomal recessive hypo-
plastic AI patient with eruption defects, crown resorption
and pulpal calcification reminiscent of ERS [26].
Clinical description
Patients are often referred to the dental practitioner due
to enamel defects of the primary and permanent teeth.
Pregnancy and delivery are uneventful, and no health
problems are observed during the perinatal period and
childhood. Patients with ERS/AIGFS present with a dis-
tinctive oral and renal phenotype (Figure 1).
Oral phenotype
Dental phenotype
Oral and radiographic examination of patients shows
consistent dental findings (Figure 1A-D). Teeth have a
yellow-brown discoloration appearance and the surface
can be either rough or smooth. Teeth are widely spacedsuggesting microdontia, albeit with normal enamel hard-
ness. Enamel layer thickness is drastically reduced, even
sometimes absent in both primary and permanent teeth
(Figure 2E). According to Witkop, such enamel dysplasia
is classified as hypoplastic enamel type IF “rough hypo-
plastic” or IG “thin/agenesis enamel” [2]. Post-eruption
wear of the irregular enamel matter may explain the ex-
tremely thin and smooth enamel that is frequently ob-
served [9]. Dental pain or sensitivity on eating or drinking
is not a prominent feature by contrast with other forms of
AI. Molar crowns show flat occlusal surfaces without any
characteristic cusp morphology. Semi-lunar shape of the
upper central incisor edge is frequently, although not sys-
tematically, observed (Figure 1A-B). Eruption of perman-
ent teeth is often delayed and sometimes completely
impaired. Delayed eruption also occurs in primary teeth
but less frequently (Figure 3A-B). These features suggest
that early morphogenetic events during odontogenesis
and eruption are affected in addition to amelogenesis.
Clinical examination must be completed with radio-
graphic analysis (Figure 1E-I). Multiple calcification nodules
(pulp “stones”) are discernible in pulp chambers in primary
and permanent teeth, typically needle-shaped in the incisors
and round in the posterior teeth (Figure 2A-B). The differ-
ential radiodensity expected between dentine and en-
amel is reduced or absent, indicating low mineral
content in enamel or absence of enamel, respectively.
Around non-erupted teeth, significant pericoronal ra-
diolucencies, delineated by sclerotic margins, are ob-
served. Despite the absence of eruption, root formation
proceeds, leading to radicular dilacerations and shorter,
sometimes curved, roots (Figure 3C-D). In addition, an
abnormal eruption pathway is noted and is extremely
clear for the second permanent molar with an inverted
direction toward the mandibular canal or maxillary
sinus. In some cases, thickening of the maxillary or nasal
sinus is observed [29]. Hyperplasia of dental follicles ap-
pears to be associated with the abnormality of the eruption
pathway and the absence of eruption (Figure 1I, Figure 3C).
On some teeth, there is extensive localized root and/or
crown resorption with partial replacement of the resorbed
dentin by lamellar haversian bone or, in some places, globu-
lar structures comprised of incompletely coalesced concen-
tric calcifications (Figure 1I) [12,18,34]. All teeth may be
affected; however, posterior teeth are more frequently
involved.
Light and scanning electron microscopy definitively
established the severe decrease in thickness or absence of
enamel (Figure 2C-H) [13]. Enamel appears as an irregular
globular calcified layer with few or absent prismatic struc-
tures. Small and sparsely packed crystals are observed par-
allel to the surface, explaining porosity of the enamel
[9,27,30]. An abnormal thick layer of what appears to be
cellular cementum, covers the roots, especially in the inter-
Table 1 All reported cases with clinical features potentially describing Enamel Renal Syndrome
Number of reported Oral phenotype Kidney phenotype Diagnosis reported FAM20A
mutationFamilies Cases ERS pathognomic
oral findings
Bilateral nephrocalcinosis
MacGibbon [5] 1 1 + + Generalized enamel hypoplasia and renal dysfunction. expected
Chosack et al. [26] 2 4 + (1/2) Not investigated Amelogenesis imperfecta among Israeli Jews and the
description of a new type of local hypoplastic
autosomal recessive amelogenesis imperfecta.
expected for
family 2 only
Lubinsky et al. [10] 1 2 + + Syndrome of amelogenesis imperfecta,
nephrocalcinosis, impaired renal concentration,
and possible abnormality
of calcium metabolism.
expected
Nakata et al. [28] 1 2 + Not investigated Interradicular dentin dysplasia associated
with amelogenesis imperfecta.
expected
Ooya et al. [27] 1 1 + Not investigated Autosomal recessive rough hypoplastic amelogenesis
imperfecta. A case report with clinical, light microscopic,
radiographic, and electron microscopic observations.
expected
Van Heerden et al. [34] 2 2 + Not investigated Amelogenesis imperfecta: multiple impactions
associated with odontogenic fibromas (WHO) type.
expected
Peters et al. [32] 1 1 + Not investigated Rough hypoplastic amelogenesis imperfecta
with follicular hyperplasia.
expected
Hall et al. [9] 1 2 + + Amelogenesis imperfecta and nephrocalcinosis
syndrome. Case studies of clinical features and
ultrastructure of tooth enamel in two siblings.
expected
Phakey et al. [14] Ultrastructural study of tooth enamel with amelogenesis
imperfecta in AInephrocalcinosis syndrome.
Dellow et al. [7] 1 2 + + Amelogenesis imperfecta, nephrocalcinosis, and
hypocalciuria syndrome in two siblings from a
large family with consanguineous parents.
confirmed3
Raubenheimer and Noffke [38] 1 1 - Not investigated Enamel dysplasia, hamartomas. not expected
Normand de La Tranchade et al. [12] 1 1 + + Amelogenesis imperfecta and nephrocalcinosis:
a new case of this rare syndrome.
expected
Paula et al. [13] 1 1 + + Case report of a rare syndrome associating
amelogenesis imperfecta and nephrocalcinosis
in a consanguineous family.
confirmed3
Cetrullo et al. [6] 1 2 - + Two cases of familial hypomagnesemia
with hypercalciuria and nephrocalcinosis:
dental findings.
not expected
Feller et al. [35] 1 1 + Not investigated Enamel dysplasia with odontogenic
fibroma-like hamartomas: review
of the literature and report of a case.
expected
Fu et al. [39] 1 1 - + Enamel-renal syndrome associated with hypokalaemic
metabolic alkalosis and impaired renal concentration:
a novel syndrome?
not expected
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Table 1 All reported cases with clinical features potentially describing Enamel Renal Syndrome (Continued)
Elisabeth et al. [40] 2 2 + (1/2) + Amelogenesis imperfecta with
renal disease–a report of two cases.
expected for
case 1 only
Feller et al. [31] 1 1 + Not investigated Enamel dysplasia hamartomatous atypical follicular
hyperplasia: review of the literature and report of a case.
expected
Roquebert et al. [33] 1 1 + Not investigated Amelogenesis imperfecta, rough hypoplastic
type, dental follicular hamartomas and gingival
hyperplasia: report of a case from Central America
and review of the literature.
expected
Martelli-junior et al. [30] 1 4 + No history of renal pathology
(but not investigated)
Case reports of a new syndrome associating
gingival fibromatosis and dental
abnormalities in a consanguineous family.
expected
Martelli-Junior et al. [11] 1 1 + + Amelogenesis imperfecta and nephrocalcinosis
syndrome: a case report and review of the literature.
expected
Dos Santos et al. [29] 11 4 + Not investigated Imaging evalution of the gingival fibromatosis and
dental abnormalities syndrome.
confirmed4
Cho et al. [11] 4 4 + Not investigated Novel FAM20A mutations in hypoplastic
amelogenesis imperfecta.
confirmed
Miloglu et al. [36] 1 2 + Not investigated Generalized familial crown resorptions in unerupted teeth. expected
Kala Vani et al. [16] 1 1 + + Enamel renal syndrome: a rare case report. expected
Hegde et al. [37] 1 2 + Not investigated Multiple Unerupted Teeth with Amelogenesis
Imperfecta in Siblings.
expected
O’Sullivan et al. [20] 11 4 + Not investigated Whole-Exome sequencing identifies FAM20A
mutations as a cause of amelogenesis imperfecta
and gingival hyperplasia syndrome.
confirmed
Jaureguiberry et al. [17] 162 25 + + Nephrocalcinosis (Enamel Renal Syndrome)
caused by autosomal recessive FAM20A
confirmed
Wang et al. [18] 3 5 + +(1/3) Family 2 FAM20A Mutations Can Cause Enamel-Renal
Syndrome (ERS)
confirmed
Cabral et al. [22] 1 12 + - Autosomal recessive gingival hyperplasia and
dental anomalies caused by a 29-base pair
duplication in the FAM20A gene
confirmed
Wang et al. [23] 2 3 + + (1/2) Neg. US in proband of Family 1 FAM20A Mutations Associated with
Enamel Renal Syndrome
confirmed
Kantaputra et al. [21] 2 2 + + Enamel-Renal-Gingival Syndrome and FAM20A Mutations confirmed
COF: Central Odontogenic Fibroma.
Neg. US: Negative ultrasounds analysis.
(+)/(−): cases positive vs. negative for the clinical features indicated. No sign: clinical features not mentioned or not investigated; + (1/2): positive in one case out of two; COF: Central Odontogenic Fibroma; 1Family
previously described in Martelli-Junior et al. [32]; 2Two families previously described in Dellow et al.; Paula et al) [7,13]; 3Family sequenced in Jaureguiberry et al. [17]; 4Family sequenced in O’Sullivan et al. [22].
(Diagnosis element were highlight by boldface).
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Figure 1 Pathognomonic oral phenotypes in patients with Enamel Renal Syndrome. (A, B, C, D, E, F, G, H) Oral views and corresponding
orthopantomogram of 4 unrelated ERS patients, all with recessive mutations in FAM20A. Oral view showing hypoplastic AI, delayed tooth
eruption, widely spaced teeth, flat cusps of posterior teeth, upper permanent central incisor crown resorption and gingival hyperplasia.
Orthopantomograms show generalized absence of enamel, altered tooth eruption pathway, flat cusps of posterior teeth (white elipse),
intra-pulpal calcification (white triangle), hyperplastic dental follicles (white diamond), and gingival hyperplasia (dashed line). Semi-lunar shape of
the permanent right upper central incisor, crown resorption and root dilacerations (white arrow) are also present. Note the consistent oral features
in all patients. (I) Summary picture of pathognomonic oral diagnosis criteria listed in orthopantomogram.
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dentinal tubules, but the dentino-enamel junction lacks its
characteristic scalloped configuration [27,33,34].
Gingival phenotype
Fibrous gingival hyperplasia is pathognomonic, with vari-
able severity. This explains why, when prominent, patients
have been diagnosed clinically as having AIGFS. Histo-
logical analysis of gingival tissue demonstrated focal ec-
topic calcification [13,30]. The gingival epithelial layer is
well structured with elongated and thin papillae. Gingival
connective tissue appears increasingly fibrous with depth,with the occurrence of focal, round ectopic calcification
near the alveolar bone (Figure 4C). Ectopic mineralization
is most often observed in close proximity to odontogenic
epithelium cells [35] and vascular vessels in rich collagen-
containing connective tissue running in all direction [30].
Different sizes of mineralized foci range from discrete
spots to confluent nodules of up to 100 μm (Figure 4C-F).
Nodules present with concentric laminations with in-
creased porosity in the center, and were suggested to be of
cementoid origin [30].
Histopathological analysis of the pericoronal follicles
of impacted teeth revealed calcified nodules similar to
Figure 2 Tooth phenotype of ERS patients. (A, B) Oral and radiograph view show intra pulpal calcification and absence of enamel (C) H&E
staining of a sagittal section from an extracted deciduous molar. (D) Magnified boxed area from C showing intra-pulpal calcification (black arrow).
(E) Magnified view of the surface of the tooth presented in C showing a sparse thin hypoplastic enamel layer. (F) Sagittal section of a deciduous
molar observed via optical microscopy (zoom ×840). Note normal tubular dentine, columnar arrangements close to the dentine indicating enamel
rods contrasting with a generally disorganized enamel surface. Note the abnormal dentino-enamel junction which is less scalloped than normal (dashed
line). (G) Magnified view of the area in F with scanning electron microscopy (zoom ×900). Note absence of normal enamel rod architecture and increased
porosity in the enamel. (H) Magnified view of box in F (zoom ×10,000). e: enamel, d: dentin, p: dental pulp, DEJ: Dentin-enamel junction (dashed line).
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features, some patients were reported to have AI associ-
ated with pericoronal hamartoma exclusively [31,33].Renal phenotype
Whilst the oral phenotype is evident in childhood, the
renal involvement is clinically silent at this age and re-
quires further investigation for detection (Table 1).
Nephrocalcinosis was reported in patients affected by
“AI and nephrocalcinosis” and by “ERS” but not ex-
plored in AIGFS patients. Renal involvement is charac-
terised by bilateral medullary nephrocalcinosis on renal
plain radiograph, ultrasound or CT imaging [8,9,12,14,16].
Renal cortex biopsies undertaken in selected patients re-
vealed focal clusters of sclerosed glomeruli, marked peri-
glomerular fibrosis with lymphocytic and plasma cell
infiltration of the renal interstitium [9,14].
Hypocalciuria and reduced citrate excretion are typical
with hypophosphatemia present less frequently [7,10,12,16].
Urine from affected patients promoted calcium oxalate
(CaOx) crystal growth compared to controls [21]. Values
for serum urea, creatinine and serum electrolytes, as well as
creatinine clearance, alkaline phosphatase, parathyroid hor-
mone, vitamin D are typically within normal limits.Aetiopathogenesis
FAM20A mutations cause both AIGFS and ERS [17-23].
Fam20a−/− mice present with the dental phenotype ob-
served in patients with FAM20A mutations, i.e., enamel de-
fects, microdontia and flat molars. The common phenotype
observed in mouse and man suggests that FAM20A plays a
role in enamel secretion and maturation stages, although
its distinct roles in amelogenesis and nephrocalcinosis
remain to be discovered. The FAM20 family includes
FAM20A, FAM20B and FAM20C proteins. FAM20C is
phylogenetically closer to FAM20A than FAM20B and has
been more extensively studied.
FAM20C is a Golgi casein kinase that phosphorylates sev-
eral secreted proteins implicated in biomineralization, in-
cluding the SIBLING proteins (small integrin-binding
ligand, N-linked glycoproteins) [41]. It is expressed by osteo-
blasts, ameloblasts (during secretion stage) and odontoblasts
and plays an essential role in tooth development [18,20,21].
Mutations of FAM20C cause autosomal-recessive neonatal
osteosclerotic bone dysplasia (Raine syndrome; OMIM
259775). FAM20B is less well understood and is not cur-
rently associated with human disease. Fam20b deletion in a
mouse model is embryonically lethal. Embryos at E12.5
show severely stunted growth, with multisystem organ hy-
poplasia and delayed development, most evident in the
Figure 3 Eruption anomalies of ERS patients. (A, B) Oral and radiographic view of no erupted or partial erupted temporary molars in a 5 years
old patient. (C, D) Cone beam radiograph of maxillary and mandible arch showing hyperplasia of dental follicle (star), dilacered root (triangle),
inverted erupting pathway : maxillary molar is seen in the sinus and mandibular molar crossed cortical bone of mandible (arrow).
Figure 4 Gingival and dental-follicle ectopic calcifications in patients with ERS. (A) Gingival hyperplasia. (B-C) H&E staining of resected
gingiva showing ectopic calcification in connective tissue. Note the lamellar concentric layer surrounding the central core of the calcification.
(D) Hyperplastic dental follicle well delimited by a sclerotic margin. (E) H&E staining of resected follicle showing a similar group of ectopic
calcification. (F) Magnification of boxed area from E. Scale bar: (E): 200 μm; (C, F): 50 μm.
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[42]. Current understanding is that FAM20B is functionally
important in cartilage matrix formation and skeletal devel-
opment by controlling proteoglycan synthesis [43].
Based on the high sequence homology of FAM20
family members, it may be speculated that FAM20A is
an additional kinase with specific targets implicated in
mineralization and/or calcium transport and proteo-
glycan synthesis. While the reported clinical features
of ERS/AIGFS primarily involve the orodental tissues
and kidneys, FAM20A expression has been detected in
additional tissues by RT-PCR: liver, lung, heart, stom-
ach, placenta, parathyroid, thymus and kidney [44].
Fam20a,b,c transcripts have been detected during
odontogenesis at mouse E14.5 molar and incisor cap
stages [45]. In situ hybridization and immunolocalization
performed in mouse mandibular incisors revealed Fam20a
expression in all enamel organ cells (ameloblasts, stratum
intermedium and stellate reticulum), odontoblasts, dental
pulp cells and suprabasal gingival epithelium, with lower
expression in the ameloblasts [20,23].
Histological analysis of Fam20a−/− mouse incisors dem-
onstrated that the ameloblast layer becomes progressively
disorganized. All other examined tissues (bone, dentine, ce-
mentum) appeared normal. Interestingly, in line with the
hamartoma phenotype reported in some human cases
[33,35], the enamel organ appeared disorganized, forming
odontogenic tumor-like structures [42]. A similar phenotype
was described in Msx2−/− mice, raising the possibility that
MSX2 and FAM20A function within a shared molecular
pathway [46]. Ectopic calcification was prominent in the kid-
neys of Fam20a−/− mice, but was also present in muscular
arteries, lungs, heart, eyes, pancreas, thalamus, uterus, chor-
oid plexus, skeletal muscle, and cutaneous tissue. Blood
levels of calcium and phosphate were normal [42].
Diagnostic criteria of ERS/AIGFS
Clinical diagnosis focuses on the association of orodental
features and renal findings that may lead on to renal im-
pairment. Ectopic lung mineralization has been reported
in one patient [21]. However, the oral phenotype is charac-
teristic and, in the absence of other co-segregating health
problems, sufficient to clinically diagnose ERS (Figure 1)
and direct genetic testing to look for FAM20A recessive
mutations (Table 1).
Orodental clinical features typical of FAM20A reces-
sive mutations include:
1) generalized thin hypoplastic or absent enamel;
2) primary and permanent teeth affected;
3) flat cusps on posterior teeth;
4) relative microdontia and spaced teeth;
5) intra-pulpal calcifications;
6) delayed tooth eruption;7) impacted posterior teeth with hyperplastic follicle
(hamartoma-like) and altered eruption pathway;
8) root dilacerations of impacted teeth;
9) gingival fibromatosis (variable severity);
10) gingival and dental follicle ectopic calcification on
biopsies;
Additional features that may be observed include:
11) semi-lunar shape of central incisor edge;
12) crown resorption of non-erupted teeth;
13) anterior open-bite;
14) root hypercementosis and inter-radicular dentine
dysplasia,
15) supernumerary teeth.
While individual features are not specific to ERS, they are
pathognomonic when they occur together in children in
the absence of other developmental abnormalities. Nephro-
calcinosis is not always detected, in part reflecting that it is
not investigated rather than due to its absence. We cannot
exclude the possibility that it is not detectable in children.
Using the orodental clinical features listed above, diagnosis
can be made as early as 5 years of age, based solely on en-
amel defects and radiographic features observed on the
panoramic radiograph. The dental radiographic images are
per se diagnostic (Figure 1I). Subsequently, such patients
should be referred to a nephrologist for evaluation and
follow-up as well as to a clinical geneticist.
Differential diagnosis
AI occurs either in isolation or as part of a syndrome (such
as Jalili syndrome [47], Raine syndrome [48], epidermolysis
bullosa [49], tricho-dento-osseous syndrome [50]). A review
of literature published since 1972 shows several reports
with confusing and incomplete characterization of ERS. Se-
vere hypoplastic enamel constitutes the first element of dif-
ferential diagnosis. Hypomaturation or hypocalcified AI
have never been described in ERS. Multiple diagnostic fea-
tures, as described above, should be present together. Iso-
lated association, such as AI and gingival fibromatosis, AI
and hamartoma, and AI and tooth delayed eruption, may
reflect other rare AI diseases. Nibali et al., for example, de-
scribed patients with gingival hyperplasia and AI [51]. En-
amel appeared as in hypomaturation type AI with diffuse
opacities covering the entire crown. No root or crown dys-
morphology was described and pulp stones were absent.
Eruption pathways and timing were normal, arguing for a
diagnosis distinct from ERS. AI and hamartoma has been
reported isolated or in several syndromes such as Cowden
syndrome [52], Von Recklinghausen disease [53], and famil-
ial tuberous sclerosis [54]. Only a few cases of them appear
to correspond to a complete description of ERS (Table 1
and Additional file 1) [31,32,35].
Table 2 List of all FAM20A mutations reported in the literature
Location cDNA Protein Mutation status Reference Patient Number of patients Sex
Exon 1 c.34_35delCT p.Leu12Alafs*67 Hom Cho et al. [19] Family 1 1 1 Female
Exon 1 c.34_35delCT p.Leu12Alafs*67 Hom Jaureguiberry et al. [17] Family 6 1 1 Male
Exon 1 c.34_35delCT p.Leu12Alafs*67 Het Jaureguiberry et al. [17] Family 16 2 2 Females
Exon 1 c.174-175ins29 p.Arg59Argfs*85 Hom Cabral et al. [22] Family 1 12 10 Males; 2 Females
Exon 1 c.217C > T p.Arg73* Het Jaureguiberry et al. [17] Family 11 2 1 Male; 1 Female
Exon 1 c.349_367del19 p.Leu117Cysfs*22 Het Kantaputra et al. [21] Family 1 1 1 Male
Intron 1 c.405-1G > C Het Wang et al. [23] Family 1 1 1 Female
Exon 2 c.406C > T p.Arg136* Hom O’Sullivan et al. [20] Family 1 4 1 Female
Exon 2 c.406C > T p.Arg136* Het Wang et al. [18] Family 3 2 2 Males
Exon 2 c.406C > T p.Arg136* Hom Jaureguiberry et al. [17] Family 5 1 1 Female
Exon 2 c.518 T > G p.Leu173Arg Hom Jaureguiberry et al. [17] Family 9 1 1 Male
Intron 2 c.589 + 1G > A Het Jaureguiberry et al. [17] Family 2 2 1 Male; 1 Female
Intron 2 c.590-2A > G p.Asp197_Ile214delinsVal Het Cho et al. [19] Family 4 1 1 Female
Exon 3 c.612delC p.Leu205Cysfs*11 Het Jaureguiberry et al. [17] Family 16 2 1 Female
Exon 4 c.641_719del p.Ile214Asnfs*46 Het Jaureguiberry et al. [17] Family 13 2 1 Male; 1 Female
Intron 4 c.719 + 1G > C Het Jaureguiberry et al. [17] Family 3 2 1 Male; 1 Female
Intron 4 c.720-2A > G p.Gln241_Arg271del Hom Wang et al. [18] Family 2 1 1 Male
Exon 5 c.727C > T p.Arg243* Het Jaureguiberry et al. [17] Family 10 1 2 Female
Exon 5 c.727C > T p.Arg243* Het Jaureguiberry et al. [17] Family 11 2 1 Male; 1 Female
Exon 5 c.755_757delTCT p.Phe252del Het Jaureguiberry et al. [17] Family 13 2 1 Male; 1 Female
Intron 5 c.812 + 2 T > G Hom Jaureguiberry et al. [17] Family 14 1 1 Female
Intron 5 c.813-2A > G p.Arg271Serfx*70 Hom Cho et al. [19] Family 2 4 3 Males; 1 Female
Exon 6 c.826C > T p. Arg276* Het Cho et al. [19] Family 4 1 1 Female
Exon 6 c.907_908delAG p.Ser303Cysfs*76 Hom Jaureguiberry et al. [17] Family 15 3 2 Males; 1 Female
Exon 6 c.913_914delTT p.Phe305Leufs*74 Het Jaureguiberry et al. [17] Family 2 2 1 Male; 1 Female
Exon 6 c.915_918delCTTT p.Phe305Leufs*76 Hom Jaureguiberry et al. [17] Family 1 1 1 Male
Exon 6 c.915_918delCTTT p.Phe305Leufs*76 Het Kantaputra et al. [21] Family 1 1 1 Male
Exon 7 c.992G > A p.Gly331Asp Hom Wang et al. [18] Family 1 3 1 Male 2 Females
Exon 8 c.1175_1179delGGCTC p.Arg392Profs*22 Hom Cho et al. [19] Family 3 2 2 Males
Exon 8 c.1207G > A p.Asp403Asn Het Wang et al. [23] Family 1 1 1 Female
Exon 9 c.1228_1229delGA p.Asp410Profs*5 Het Jaureguiberry et al. [17] Family 10 1 1 Female
Intron 9 c.1302-2A > G Het Kantaputra et al. [21] Family 2 1 1 Female
Exon10 c.1348_1349delTC p.Ser450Profs*20 Het Jaureguiberry et al. [17] Family 3 2 1 Male; 1 Female
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Table 2 List of all FAM20A mutations reported in the literature (Continued)
Intron 10 c.1361 + 4del Hom Wang et al. [23] Family 2 2 1 Male; 1 Female
Exon 11 c.1369A > T p.Lys457* Hom Jaureguiberry et al. [17] Family 12 1 1 Female
Exon 11 c.1432C > T p.Arg478* Hom Jaureguiberry et al. [17] Family 8 1 1 Male
Exon 11 c.1432C > T p.Arg478* Het Wang et al. [18] Family 3 2 1 Male; 1 Female
Exon 11 c.1480delC p.His494fs*13 Het Kantaputra et al. [21] Family 2 1 1 Female
Exon 11 c.1475_1482dupAACCCCAC p.Leu495Asnfs*15 Hom Jaureguiberry et al. [17] Family 4 2 1 Male; 1 Female
Exon 11 c.1513delA p.Ile505Serfs*2 Hom Jaureguiberry et al. [17] Family 7 2 1 Male; 1 Female
Total reported 40 (33 unique mutations) 18 Hom; 22 Het 29 Families 60 index cases 32 Males; 28 Females
Hom: homozygous; Het: heterozygous; *premature stop codon.
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present in pathologies other than ERS. Enamel defects are
a frequent finding (58.3%) in patients affected by renal dis-
orders [55]. Indeed, the kidney is central to regulation of
calcium and phosphate homeostasis. Different renal pro-
teins previously known to play a role in the systemic pH
homeostasis in mammals, have also been described to be
expressed during amelogenesis: the carbonic anhydrase II
[56], the acid–base exchangers AE2, NBCe1 and NHE1
[57,58]. Suda et al. described a patient with severe AI and
polycystic kidney disease leading to nephrocalcinosis [15],
caused by a mutation in MSX2. Panoramic radiography re-
vealed no pulpal stones and no eruption anomalies. Fu
et al. described a patient with ERS associated with hypo-
kalemic metabolic alkalosis and impaired renal concentra-
tion [39]. Besides nephrocalcinosis, the dental and renal
phenotypes did not correspond with those seen in ERS,
suggesting this patient was wrongly diagnosed with ERS.
This reinforces the importance of a detailed oral clinical
examination, rather than exclusively focusing on AI.
Genetics and genetic counseling
Combining homozygosity mapping and whole exome
sequencing, O’Sullivan et al. identified the first homozy-
gous mutation in FAM20A in a consanguineous family
with AIGFS [20]. To date, 40 (33 unique) recessive
FAM20A mutations have been identified in 29 ERS fam-
ilies (MIM#204690) (Table 2), ERS/AIGFS is a recessive
inherited disease with either homozygous or combined
heterozygous FAM20A mutations and is likely one
unique syndrome. Heterozygous carriers appear to be
phenotypically healthy. FAM20A is located on chromo-
some 17q24.2, is 65,839 base pairs long and consists of
11 exons. All but 2 of the 33 identified mutations lead
to premature stop codons (Table 2). The remaining two
are non-synonymous mutations in well-conserved re-
gions of the protein [18].
Natural history and prognosis
Pediatric dentists are usually the first health practitioners
to see affected patients due to AI and delayed eruption of
permanent teeth. Due to the association of this specific
oral phenotype with nephrocalcinosis, patients should be
referred to a nephrologist for assessment. The natural evo-
lution of nephrocalcinosis associated with FAM20A muta-
tions is not well established. Two patients were reported
to have died prematurely before the age of thirty: one had
coronary occlusion and the other developed chronic py-
elonephritis [5]. One author reported that the medullary
calcification became coarser and denser as his patients
aged from 8 years to 14 years old [10]. Three patients ex-
perienced acute or chronic pyelonephritis, 1 had urinary
calculus [7,9,14] and 1 developed chronic renal failure [8].
For the remaining patients with nephrocalcinosis, noanomalies or major complications were reported [11-13,17],
in line with the clinical history of Fam20a−/− mutant
mice, which depicted a partial resolution of ectopic
mineralization in muscular arteries and lungs as the
mice matured [42]. A regular follow-up of the nephro-
calcinosis and evaluation of kidney function throughout
childhood and adulthood may enable the initiation of
preventive treatment before the occurrence of renal
failure.
Except for gingival hyperplasia, for which gingivectomy is
successful with no recurrence reported, the orodental
phenotype is often complex to manage [30,33]. AI results
in considerable morbidity; affected individuals have teeth
with poor function and aesthetics, have lower self-esteem
and report an inferior quality of life [59]. Dental wear and
aesthetics are the main motives for the initial consultation,
but absence of eruption is the most challenging problem to
solve. Only erupted teeth can be restored with conventional
treatments such as ceramic crowns for example [8]. More
severe cases are however characterized by a large number
of non-erupted teeth, forcing complete rehabilitation with
overdentures. Long-term follow-up reveals that teeth with
follicle hyperplasia do not erupt and the extraction of pri-
mary teeth does not facilitate the eruption of permanent
teeth. Orthodontic traction has been tested to bring them
in occlusion, but results have been slow and inconsistent.
The absence of a global therapeutic consensus concerning
non-erupted teeth complicates dental surgery.Conclusion
A careful review of the published literature and case
reports highlights a significant overlap in the oral
phenotype between cases of AI with hamartomas,
unerupted teeth, AIGFS and ERS. Recently, recessive
mutations in FAM20A were shown to be responsible
for both AIGFS and ERS. Supported by the phenotype
observed in Fam20a null mice, human phenotypic and
genetic data suggest that, rather than being allelic, ERS
and AIGFS are in fact the same syndrome. The pheno-
type is characterized by severe enamel hypoplasia, de-
layed or absent tooth eruption, ectopic eruption
pathway, and pulp and gingival calcification in tempor-
ary and permanent dentition. Gingival hyperplasia typ-
ically accompanies these features but is more variable,
ranging from discrete to severe. We propose that all af-
fected patients be categorized under the term ERS, and
that the 2 OMIM entries (ERS: MIM#204690, AIGFS:
MIM#614253) be fused. Since the oral phenotype in
the absence of other developmental health problems is
pathognomonic, dentists have a key role in the diagno-
sis and referral of patients to both nephrologists for
renal assessment and to geneticists to identify the
causative FAM20A mutations.
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